Canadian Institute for Health Information (2009) Health Indicators 2009 (Ottawa, Ont.: CIHI, 2009) 29. Blume SW, Curtis JR (2010) Medical costs of osteoporosis in the elderly Medicare population. Alvocidib Osteoporos Int Dec 17 30. Brecht

JG, Schadlich PK (2000) Burden of illness imposed by osteoporosis in Germany. HEPAC 1:26–32CrossRef 31. Brown P, McNeill R, Leung W, Radwan E, Willingale J (2011) Current and future economic burden of osteoporosis in New Zealand. Appl Health Econ Health Policy 9(2):111–123PubMedCrossRef 32. Clark P, Carlos F, Barrera C, Guzman J, Maetzel A, Lavielle P, Ramirez E, Robinson V, Rodriguez-Cabrera R, Tamayo J et al (2008) Direct costs of osteoporosis and hip fracture: an analysis for the Mexican healthcare system. Osteoporos Int 19(3):269–276PubMedCrossRef 33. Haussler B, Gothe H, Gol D, Glaeske G, Pientka L, Felsenberg D (2007) Epidemiology, treatment and costs of osteoporosis in Germany—the BoneEVA Study. Osteoporos Int 18(1):77–84PubMedCrossRef 34. Johnell O, Kanis JA, Jonsson B, Oden A, Johansson H, De Laet C (2005) The burden of hospitalised fractures in Sweden. Osteoporos Int 16(2):222–228PubMedCrossRef 35. Lippuner K, Golder M, Greiner R (2005) Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland. Osteoporos Int 16(Suppl 2):S8–S17PubMedCrossRef 36. Maravic M, Le BC, Landais P, Fardellone P (2005)

Incidence and cost of osteoporotic fractures in France

during 2001. A methodological approach by the national hospital database. Osteoporos Int 16(12):1475–1480PubMedCrossRef 37. Ray NF, Chan JK, Thamer M, Melton see more LJI (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12(1):24–35PubMedCrossRef 38. Bessette L, Jean S, Lapointe-Garant MYO10 MP, Belzile EL, Davison KS, Ste-Marie LG, Brown JP (2011) Direct medical costs attributable to peripheral fractures in Canadian post-menopausal women. Osteoporos Int Sep 17 39. Leslie W, O’Donnell S, Lagace C, Walsh P, Bancej C, Jean S, Siminoski K, Kaiser S, Kendler D, Jaglal S et al (2010) Population-based Canadian hip fracture rates with international comparisons. Osteoporos Int 21(8):1317–1322PubMedCrossRef”
“Erratum to: Osteoporos Int DOI 10.1007/s00198-011-1870-0 The third author’s name was rendered incorrectly. The correct name is A. DeCensi.”
“Erratum to: Osteoporos Int DOI 10.1007/s00198-011-1878-5 The third author’s name was rendered incorrectly. The correct name is N. Lo Iacono.”
“Dear Editor, In their recent paper, Anagnostis et al. [1] described a rare case of association of parathyroid hormone (PTH) 1–34 and 1–84 treatment with de novo autoimmune hepatitis (AIH) after liver Apoptosis inhibitor transplantation (LT). They excluded common causes of liver dysfunction such as viral infections or medication-induced hepatotoxicity.